Dr. Raman Bahal, CPPR Faculty, is the 2025 recipient of the UConn School of Pharmacy Faculty Research Advising Award. He is a world leader in developing novel technologies at the nucleic acid chemistry and biology interface to target genomic DNA and RNA for treating diseases that are unavailable elsewhere. Over the past seven years, he has mentored 24 Pharm.D. and undergraduate students, demonstrating his commitment to shaping the next generation of pharmaceutical professionals.
CPPR Student, Saurav Adhikari, from the lab of Professor Na Li was named the Steve Nail Emerging Researcher at the CPPR Scientific Conference held at Purdue University in November 2024. Steve was on-hand to present the award.
CPPR Faculty, Dr. Na Li and Dr. Bodhi Chaudhuri from University of Connecticut, and Dr. Li’s student, DaHye Yang, describe how the particle drifting effect leads to increased drug absorption rates in a recent publication in Molecular Pharmaceutics. Read more about the mechanisms of this fascinating phenomenon at https://doi.org/10.1021/acs.molpharmaceut.4c00751.
CPPR Faculty, Dr. Na Li from University of Connecticut, and her student, Akshay Narula, published their findings on the growth mechanisms of amorphous nanoparticles in the Journal of Pharmaceutical Sciences. Read more at https://doi.org/10.1016/j.xphs.2024.08.017.
AIChE ‘s Fellow is the organization’s highest membership grade. AIChE fellow candidates are nominated by their peers and must have significant professional accomplishment, exceptional contribution in the field of chemical engineering, and those who have demonstrated long-term excellence in the profession. New AIChE Fellows will be recognized at the upcoming AIChE Annual Meeting, Oct. 27-31, in San Diego, California
CPPR Faculty, Raj Suryanarayanan from University of Minnesota, and his co-authors, Jinghan Li, Bhushan Munjal, Chaowang Zeng, published their findings on the dual functionality of poloxamer 188 in freeze-dried protein formulations in Molecular Pharmaceutics. Read more at https://doi.org/10.1021/acs.molpharmaceut.4c00108. 
DIANT® Pharma Inc, well known for their continuous nanoparticle and LNP processing systems, launches LARU Discovery, a highly innovative nanoparticle research system. Read more at DIANT Pharma Inc Launches “Highly Innovative” Nanoparticle Research System: Laru Discovery | Markets Insider (businessinsider.com).
Congratulations to Tony for becoming a named professor. His new title is Jack and Barbara McCoy Associate Professor.
The David J. W. Grant Distinguished Scholar award is given every other year by NIPTE for outstanding achievements in basic pharmaceutics. Diane Burgess, UConn CPPR faculty, received this prestigious award in 2024. For more, click on Diane Burgess Wins David J. W. Grant Distinguished Scholar in Basic Pharmaceutics Award – UConn Today.
Otsuka joins Alexion, Astrazeneca, ATS Scientific Products, Boehringer-Ingelheim, Gilead Sciences, Glaxosmithkline, Lilly, Roquette, and Sanofi on the CPPR Industrial Advisory Board. We look forward to Otsuka’s participation in our quest to advance pharmaceutical processing. The funds that Otsuka has committed to CPPR research are pooled with those of the other member companies. The funds support rigorous academic research into industrially relevant pharmaceutical processing research at the CPPR academic sites, with mentorship from representatives from CPPR companies.
